Portfolio
Saint Capital
Team
Portfolio
all investments
ibs
communications
consumer services
healthcare
semiconductor
software
Saints Advisors
Contact
Home

HEALTHCARE
Acorda Therapeutics (NASDAQ: ACOR) was established to develop therapies that restore neurological function to people with spinal cord injury (SCI), multiple sclerosis (MS) and related conditions of the nervous system.
View site ››
AcousTx is an early stage medical device company dedicated to developing image guided therapeutic medical products to treat significant medical needs.
View site ››
 

Alliance Life Sciences is a management and technology consultancy that specializes in providing asset-based solutions that address the revenue and customer management challenges that pharmaceutical manufacturers face today. 
View site ››

 
Arcadia Biosciences is an agricultural biotechnology company focused on the development of agricultural products that improve the environment and enhance human health.
View site ››
Asthmatx Inc. designs, develops and manufactures catheter based medical devices incorporating thermal energy for a variety of indications.
View site ››
 
Biolex Therapeutics is developing and commercializing therapeutic proteins based on its proprietary LEX System, an expression system that enables the production of hard-to-make proteins and the optimization of monoclonal antibodies.
View site ››

Beta-O2 is a biomedical company that created a technology that enables adequate oxygen supply to cells and organs transplanted in oxygen-poor sites in the body.
View site ››

 

Exited in 2009
Bioheart Inc. (NASDAQ: BHRT) is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
View site ››

 

Exited in 2009
Biophan Technologies (FWB:BTN) is a technology development company serving the healthcare industry, focused on commercializing the Myotech Circulatory Support System (CSS) - a novel, non-blood-contacting heart pump for patients with acute heart failure.
View site ››

 
Biosurface Engineering Tech
View site ››
   
Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases.
View site ››
 

Carbon Medical Technologies develops, manufactures and markets proprietary carbon-coated implantable medical devices.
View site ››

 

Cardiofocus is dedicated to the advancement of ablation treatments for cardiac disorders.
View site ››

 

CardioMEMS has developed and is commercializing a proprietary wireless sensing and communication technology for the human body.
View site ››

 
Exited in 2009
CardioNet (NASDAQ: BEAT) is a supplier of mobile cardiac outpatient telemetry. CardioNet provides the next-generation ambulatory cardiac monitoring service with beat-to-beat, real time analysis, automatic arrhythmia detection and wireless ECG transmission.
View site ››

 

Cascade Ophthalmics, develops innovative device-based solutions for the treatment of glaucoma.
View site ››

   
Cianna Medical is a women's health company dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and markets the SAVI breast brachytherapy applicator.
View site ››
Coapt designs, develops, manufactures and markets bio absorbable implants specifically to provide surgeons with the next generation of soft tissue fixation technology.
View site ››
CoAptus Medical Corporation is an early stage medical device company developing a therapeutic product for the treatment of a structural heart defect called a patent foramen ovale, or PFO.
View site ››
 
CoAxia™ is a development stage, medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke.
View site ››
 

DiscoveRx® develops, manufactures, and commercializes reagents and complete assay kits for the drug discovery and screening markets.
View site ››

 
Acquired by Allscripts (NASDAQ: MDRX) in 2008
Extended Care Information Network's (ECIN) business to business products and services use Internet-based connectivity to fully automate and enhance the discharge planning process for hospitals and health systems.
View site ››
Investment managed but not owned:
Emageon (NASDAQ: EMAG) provides a suite of products and services that allows physicians and healthcare professionals to manage, access, and visualize multi-specialty medical content across the enterprise using advanced visualization tools and specialized workflow through a dynamic user interface.
View site ››
E-Pill Pharma provides an effective new platform for oral delivery of drugs that are currently administered parenterally (by injection or intravenously).
View site ››
 

Epitek develops, manufactures, and markets a surgical instrument The Anchorage Closure Device™ to occlude, ligate or appose soft tissue.
View site ››

 
For 10 years ESTECH has been the source for innovative technology that enables surgeons to deliver effective care by ensuring reproducible surgical outcomes and making potentially challenging procedures easier to perform. At ESTECH we pride ourselves in offering the cardiothoracic surgeon minimal access instruments that are the most durable and dependable on the market today.
View site ››
 
Acquired by Abbott
Evalve designs, develops, manufactures and markets innovative devices to enable percutaneous repair of cardiac valves.
View site ››
 

F.D. Cardio invented in a unique technology platform to facilitate catheter use for interventional cardiology, interventional neurology and others, with pushing force and maneuverability capabilities in the front distal therapeutic part of the catheter.

Exited in 2009
FlowMedica develops minimally invasive intravascular systems for implementing Targeted Renal Therapy (TRT™)  which is the delivery of therapeutic agents to the kidneys via the renal arteries.
View site ››

 

Garnet BioTherapeutics is a pioneer in the use of adult bone marrow-derived somatic cells (hABM-SC).
View site ››

 
Genesis Medical Interventional, is a funnel catheter company committed to advancing cardiovascular healthcare by designing safe, easy-to-use products to treat occlusive vascular diseases.
View site ››
 
GMP Companies was originally founded as a healthcare company seeking to acquire, develop and commercialize novel medical technologies. Today, LifeSync Corporation is the sole business of GMP Companies. LifeSync produces wireless patient monitoring leads and transceivers to create a Personal Area Network between patient and monitor. View site ››    

Hemosphere, is developing technologies that restore quality of life for patients with compromised vasculature.
View site ››

 
Illumina develops tools for the large-scale analysis of genetic variation and function.
View site ››
ImaRx Therapeutics (NASDAQ:IMRX.OB) is a biopharmaceutical company developing and commercializing therapies for vascular disorders.
View site ››
 
InnFocus is a biomaterials-based company established to develop novel products in ophthalmology that are not readily achievable with traditional biomaterials.
View site ››
 
InnoGraft LLC was spun off from Innovia in 2003 to develop novel sealants for conventional large caliber vascular grafts and to leverage this technology to enable small caliber vascular grafts.
View site ››
 
ITI is a world leader in the manufacture of Nitinol materials and components for medical device OEM's.
LifeMasters provides technology-enabled chronic-disease management services to individuals, physicians and payors.
View site ››
Laureate Pharma provides bioprocessing services that accelerate new products from development through production.
View site ››
 
Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs.
View site ››
Exited in 2009
Lombard Medical Technologies (FTSE:LMT) develops, manufactures and markets stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings.
View site ››
 

Medcool develops and manufactures non-invasive, therapeutic temperature reduction solutions for emergency medicine and intensive care applications.
View site ››

 
Acquired by WebMD (NASDAQ: WBMD) in 2006
eMedicine provides a Clinical Knowledge Base available to physicians and health professionals.
View site ››

MediGuide develops tracking and imaging technologies for use during minimally-invasive surgical procedures.
View site ››

 
Medivas has pioneered a unique drug and biologic delivery system through the use of a new family of biodegradable polymers.
View site ››
 

Acquired by WebMD (NASDAQ: WBMD) in 2006
Medsite uses the power of the Internet to provide a full suite of online marketing and educational services that broaden reach, cement relationships, and deliver rewards to physicians.
View site ››

MedVantx created the first Generic Delivery Network that benefits payors, physicians and patients by providing first-line generic medication therapy free to patients at the point of care.
View site ››

MicroCHIPS is pioneering intelligent implanted devices designed to improve the health of people with chronic conditions that require careful monitoring and precise therapy.
View site ››

 
Natural Pharmaceuticals produces a sustainable supply of semi-synthetic paclitaxel API for clinical research and commercial sales at competitive prices for the gobal market. NPI additionally produces docetaxel.
View site ››
 
NAVIX provides a turnkey solution for the funding, operation, maintenance and updating of a diagnostic testing program. Our fixed site and mobile options provide the right equipment at the right place with the right schedule and superior technologists.
View site ››
 
Neovasc develops, manufactures and markets vascular and surgical devices. Its products include the Metricath® for intravascular measurement, PeriPatch™ for surgical tissue repair, PeriPatch™ Aegis for staple line reinforcement and a pipeline of new products under development.
View site ››
 
Notal Vision is developing the first comprehensive diagnostic solutions for the early detection and frequent monitoring of Age-Related Macular Degeneration, the leading cause of blindness in the western world today.
View site ››
Exited in 2009
OccuLogix (NASDAQ:TEAR) is a health care company focused on evidence-based ophthalmic devices for the diagnosis and treatment of age related eye diseases.
View site ››
 
Orqis Medical is developing devices that prevent or reverse the underlying disease progression of heart failure.
View site ››
 
Passport Health is a provider of travel medical services in the United States with convenient locations nationwide.
View site ››
 
PatientKeeper provides healthcare professionals with mobile computing solutions that help improve patient care and curb rising costs.
View site ››
POINT Biomedical was founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphere.
View site ››

Power Medical Interventions® is develops Intelligent Surgical Instruments™ for bariatric, cardiothoracic, colorectal and general surgical applications.
View site ››

 
Primary Health is an integrated health care delivery system consisting of a managed care insurance company (Primary Health Plan), a multi-specialty medical group (Primary Health Medical Group), and a provider network (Idaho Physician's Network).
View site ››
 
Acquired by Wolters Kluwer in 2006
ProVation provides a multi-disciplinary documentation solution with a growing array of specialty medical-content cartridges that run on a single, powerful platform.
View site ››

Proxy Biomedical develops medical products using proprietary biomaterials technology.
View site ››

 

Acquired by Hologic (NASDAQ: HOLX) in 2006
R2 Technology offers development and commercialization of computer aided detection (CAD), an innovative technology that assists physicians in the earlier detection of breast cancer, actionable lung nodules and other lung abnormalities.
View site ››

Acquired by MacroGenics in 2008
Raven Biotechnologies is focused on the development of monoclonal antibody therapeutics for treating cancer.
View site ››
REVA Medical develops interventional medical devices that leverage the stent designs and biomaterials to improve the treatment of vascular disease.
View site ››
 
Solace Therapeutics is a medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS).
View site ››
 
Spiration is developing therapies that improve the quality of life for patients with acute and chronic conditions of the lungs.
View site ››
 

superDimension develops and markets minimally-invasive pulmonology devices that enable the diagnosis and potentially the treatment of distal lung disease.
View site ››

 
TEI Biosciences has applied its expertise in regenerative medicine to develop and commercialize novel biologic products for a broad spectrum of soft tissue repair and reinforcement applications - from dura, tendon, and hernia repair to wound management and plastic and reconstructive surgery.
View site ››
 

Therapeutics is a drug development company focused on dermatology-related areas of medicine.
View site ››

 
Theregen is a regenerative medicine company that is developing cell-based therapies for cardiovascular indications. Anginera™, Theregen's lead product, is an epicardial patch designed to improve cardiac function in patients.
View site ››
 
Therus is developing the Therus® Acoustic Hemostasis System, a medical device designed for rapid, durable, noninvasive sealing of femoral artery access punctures following catheterization-laboratory procedures such as angiography and angioplasty.
View site ››
 

Tissuemed develops tissue-based therapeutic devices including the first tissue heart valve to gain regulatory approval in Europe, subsequently developing "living" vascular grafts and collagen patches.
View site ››

 
Exited in 2009
VIA Pharmaceuticals (NASDAQ:VIAP) is a biotechnology company focused on the treatment of cardiovascular disease.
View site ››
 

Viron Therapeutics is a clinical stage biopharmaceutical company developing a completely new class of anti-inflammatory therapeutics to treat and prevent human inflammatory disorders. Viron's novel approach to drug development is based on the use of viral proteins as a source of therapeutic products.
View site ››


VisionCare Ophthalmic Technologies is a privately-held development stage company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.
View site ››
 

WideMed offers signal analysis and workflow management services and solutions to the Cardio-Sleep market.
View site ››

 
Zonare designs, develops, and manufactures high performance portable ultrasound products, which combine revolutionary technology with an innovative physical design to achieve unsurpassed customer value in the global ultrasound market.
View site ››